Calculus leads £6.7m funding round into Tagomics
Summary
This achievement follows a \xa31.6m pre-seed round led by IQ Capital and Start Codon and including grant funding from Innovate UK. The investment will accelerate Tagomics scientific research and product development, with the goal of delivering improvements in cancer and other diseases diagnosis and treatment. By integrating these methods and applying advanced data analysis and machine learning, the Tagomics platform can provide a 360\xb0 understanding of human health and disease. Were pleased to welcome such an experienced group of investors on board to help us accelerate the development of our platform and support our efforts in expanding the capabilities of genomic medicine.Elizabeth Klein, Investment Director at Calculus, said: We are delighted to support Tagomics as the company embarks on its next phase of expansion, applying its innovative technology to discover new markers for disease diagnosis and management. We expect that our investment of capital, lab facilities, and sequencing technologies, alongside other syndicate members will accelerate Tagomics path to market.